Description x Elevate your weight loss journey with Phytolaca Berry Tablets! Our slimming tablets harness the power of natural ingredients to support healthy weight management. Experience the benefits of Phytolaca berry for effective slimming. Take the first step towards your goals today! INDICATION: Phytolacca berry is indicated for obesity, overweight, and extra fat in the body. Phytolacca berry naturally dissolves unwanted fats in the body. Controls obesity by burning fat, making the body slim and smart. Phytolacca berry is a natural and safe medicine. DOSAGE: 2 tablets to be taken three times a day before meals or as prescribed by a homeopathic doctor. Presentation: Available in 75 tablets packing. Product Enlistment No: 0079790437 Read more
Phytolacca Berry Tablets
Elevate your weight loss journey with Phytolaca Berry Tablets! Our slimming tablets harness the power of natural ingredients to support healthy weight management. Experience the benefits of Phytolaca berry for effective slimming. Take the first step towards your goals today!
INDICATION:
Phytolacca berry is indicated for obesity, overweight, and extra fat in the body.
Phytolacca berry naturally dissolves unwanted fats in the body.
Controls obesity by burning fat, making the body slim and smart.
Phytolacca berry is a natural and safe medicine.
DOSAGE:
2 tablets to be taken three times a day before meals or as prescribed by a homeopathic doctor.
Presentation:
Available in 75 tablets packing.
Product Enlistment No:
0079790437
₨170.00
Related products
-
Agaricus muscarius Q
₨450.00 – ₨1,380.00Price range: ₨450.00 through ₨1,380.00 -
Femi Pro Syrup
₨290.00 -
Kalmin CF Tablets
₨370.00
Recently Viewed Products
-
Reset and Slim
₨1,200.00Original price was: ₨1,200.00.₨1,080.00Current price is: ₨1,080.00. -
Kidney and Bladder
₨250.00Original price was: ₨250.00.₨225.00Current price is: ₨225.00. -
Psorinum
₨240.00 – ₨500.00Price range: ₨240.00 through ₨500.00 -
SPONGIA TOSTA
₨280.00 – ₨690.00Price range: ₨280.00 through ₨690.00










Reviews
There are no reviews yet.